Thymic carcinoma overview: Difference between revisions
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Thymic carcinoma is a rare condition (less than 0.13/100,000/year) but should be included in the differential diagnosis of anterior mediastinic masses. It is a tumor of the thymic epithelium, like thymoma, but it is associated with lack of immature lymphocytes and often presents with more invasive or metastatic disease. | Thymic carcinoma, also known as type C thymoma is a rare condition (less than 0.13/100,000/year) but should be included in the differential diagnosis of anterior mediastinic masses. It is a tumor of the thymic epithelium, like thymoma, but it is associated with lack of immature lymphocytes and often presents with more invasive or metastatic disease. | ||
Thymic carcinomas can metastasize, generally to pleura, kidney, bone, liver or brain | Thymic carcinomas can metastasize, generally to pleura, kidney, bone, liver or brain |
Revision as of 18:49, 27 February 2014
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma overview On the Web |
American Roentgen Ray Society Images of Thymic carcinoma overview |
Risk calculators and risk factors for Thymic carcinoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Thymic carcinoma, also known as type C thymoma is a rare condition (less than 0.13/100,000/year) but should be included in the differential diagnosis of anterior mediastinic masses. It is a tumor of the thymic epithelium, like thymoma, but it is associated with lack of immature lymphocytes and often presents with more invasive or metastatic disease.
Thymic carcinomas can metastasize, generally to pleura, kidney, bone, liver or brain